to main content Coronavirus (COVID-19) Guidance and Resources | The Joint Commission

The Joint Commission recognizes the incredible challenge that health care organizations and front-line workers face with the COVID-19 crisis.

Statements to Support Our Health Care Providers 

August 14, 2020 – Removal of Position Statement

May 27, 2020 – Regular Surveys and Reviews to Resume in June — With Some Changes to Protect Safety

May 12, 2020 – Statement on Removing Barriers to Mental Health Care for Clinicians and Health Care Staff 

For additional statements, please see Webinars and Communications from The Joint Commission below.

COVID-19 Lessons Learned: A Resource for Recovery 

This new whitepaper, co-authored by Deloitte & Joint Commission Resources, covers specific actions that organizations have taken to address issues and provides access to guidance and tools that health care leaders can use to create and enact their own plan to address these challenges.

View whitepaperVisit JCR to read the whitepaper

Offsite (Formally Virtual) Survey and Review Framework: A New Approach for Conducting Surveys and Reviews During the Pandemic

More information on what you can expect:

Educational Videos about Vaccination and the COVID-19 Vaccine

CDC and National Alliance of Healthcare Purchaser Coalitions:

Resources related to personal protective equipment:

IDSA recommendations on PPE when caring for COVID patients

Face Mask Posters and Infographics

Videos - Consistent with CDC recommendations as of March 24, 2020 

As of March 24, 2020, CDC recommends:

  • Contact Plus Droplet plus Eye Protection when providing routine care to known or suspected COVID-19 patients. 
  • Airborne Plus Droplet plus Eye Protection when performing aerosol generating procedures on known or suspected COVID-19 patients. 

These videos provide an example using disposable gowns.  It is essential that the instructions to employees take into account the specific PPE the facility is using (e.g., reusable versus disposable gown, N95, PAPR, or surgical mask, goggles, glasses with side shields, or faces mask) being used as well as the physical layout (e.g., ante-room, no ante-room, multiple patient room) and how the organization is utilizing the PPE (e.g., single use, reuse, or extended use). 

Combinations of PPE should be considered.  For example, if practicing extended use of N95 respirators (recommended by NIOSH) the organization should consider using face shields that will protect the respirator from splashes or splatters and prevent staff from inadvertently touching surfaces of the respirator while in use.

CDC Guidance on Managing Critical Shortages

CDC Guidance on Optimizing the Supply of PPE During Shortages

  • Summary Strategies to Optimize the Supply of PPE during Shortages

FDA Guidance on Managing Critical Shortages

Note: In reviewing FDA guidance on strategies to conserve gloves, you need to know what type of gloves you use in your facility (e.g., latex, vinyl and nitrile). It is safe to use alcohol-based hand rub on latex and nitrile gloves. But the FDA states that alcohol is not recommended for cleaning vinyl gloves because it may degrade them.  

Guidance related to ventilators:

There are intensive efforts underway across the country to try to ensure that the supply of ventilators in the U.S. will be adequate to meet the needs of all COVID-19 patients requiring one. Healthcare leaders and clinical directors should review the FDA’s guidance and the other resources below on mitigation strategies when facing ventilator shortages.

If Shortages Occur Despite Mitigation Strategies
Even with these mitigation strategies, the possibility remains that shortages will occur, and clinicians and healthcare leaders will face the decision of whether to place two patients with COVID-19 on a single ventilator. Experts have differing opinions about whether ventilator sharing can be done safely and effectively. The Joint Commission does not endorse any position because there is not sufficient evidence to guide us. In such situations, we usually remain silent, but we think it is important to provide resources for those who might be facing this difficult decision.

The Society of Critical Care Medicine, in partnership with several other organizations, advises clinicians to not attempt to share mechanical ventilators because it cannot be done safely: “Attempting to ventilate multiple patients with COVID-19…could lead to poor outcomes and high mortality rates for all patients cohorted. …it is better to purpose the ventilator to the patient most likely to benefit than fail to prevent, or even cause, the demise of multiple patients” (March 2020).

However, SCCM’s Mechanical Ventilator Strategies page also included a section labeled “When You’re Out of Options” which provided links to resources for mechanically ventilating two patients with a single ventilator in crisis situations.


Other organizations have drawn different conclusions and have provided advice on how to set up systems to share ventilators in March/April 2020:

More recently, the FDA released a letter to Health Care Providers in February 2021, containing the following text and a link to the most current version of the GNYHA/NY Presbyterian Ventilator Sharing Protocol (version 6):

The FDA is informing health care providers and health care facilities about up-to-date information concerning multiplexing ventilator tubing connectors, also known as ventilator splitters, in situations in which no alternatives for invasive ventilatory support are available. Although the FDA has not received any adverse event reports related to the use of ventilator splitters authorized for emergency use during the COVID-19 pandemic, recent literature describes risks that may be associated with using certain ventilator splitters. After considering this recent literature, the FDA is informing health care providers and health care facilities that the literature indicates that certain features are associated with better performance.

High Flow Nasal Oxygen

  • Some patients can be effectively managed on nasal oxygen including high flow, but the risk of aerosolization should be considered and managed. The use of high‐flow nasal oxygen in COVID‐19
  • An FAQ from the ASA says that if patient oxygenation is not maintained on low-flow oxygen, higher oxygen flows may be unexpectedly needed that might increase aerosolization of COVID-containing respiratory secretions. Each patient will need to be evaluated on a case-by-case basis to consider the balance of aerosolization at the oxygen flow needed to maintain a satisfactory oxygen saturation, and whether to convert to a more closed airway system (LMA or ETT). How should I deliver supplemental O2 to a patient who is wearing a mask and who has or may have COVID-19? (View under Clinical Care section)

FDA Guidance

Other Guidance

Resources related to staffing and telehealth:
Additional resources available regarding COVID-19:
Ambulatory health care-specific resources:

Note: For resources regarding PPE, please see the PPE section. For resources regarding Telehealth, please see the Staffing and Telehealth section.

Joint Commission Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety and Joint Commission standards.

Joint Commission FAQs

CDC Resources 

Note: CDC Updates infection prevention and control guidance during the COVID pandemic regularly. Please refer to this guidance in addition to the resources listed here.

CMS Resources

FDA Resources

Preparing for COVID-19 Vaccination

Other Resources

Resources Specific to Re-opening/Continuing of Services

Resources Specific to Secondary Disasters (e.g., Hurricanes)

Behavioral health care and human services specific resources:
Home care-specific resources:

Note: For resources regarding PPE, please see the PPE section. For more resources regarding Telehealth, please see the Staffing and Telehealth section. 

Leaders from The Joint Commission answer questions on topics including infection prevention and control, 1135 waivers and telehealth.

Infographics

Joint Commission FAQs

CDC Resources

Note: CDC Updates infection prevention and control guidance during the COVID pandemic regularly. Please refer to this guidance in addition to the resources listed here.

Preparing for COVID-19 Vaccination

Resources Specific to Hospice

Resources Specific to Pharmacy Infusion/Specialty/Ambulatory Infusion

Joint Commission FAQs

FDA Resources

Hospital-specific resources:

Note: For resources regarding PPE, Ventilators and other relevant topics, please see the appropriate section on this webpage.

Joint Commission Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, life safety and 1135 waivers.

Disease-Specific Care Q&A Webinar

Recommendations on Hospital Surge Capacity

Infographics

FDA Resources

Preparing for COVID-19 Vaccination

Note: CDC Updates infection prevention and control guidance during the COVID pandemic regularly. Please refer to this guidance in addition to the resources listed here.

Laboratory services-specific resources:

Note: For resources regarding PPE, please see the PPE section.

Joint Commission FAQs

Joint Commission Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety, CMS 1135 Waivers, and Joint Commission standards.

CDC Resources

Note: CDC Updates infection prevention and control guidance during the COVID pandemic regularly. Please refer to this guidance in addition to the resources listed here.

FDA Resources

CMS Resources

Nursing care center-specific resources:

Note: For resources regarding PPE, please see the PPE section.

Joint Commission Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety, CMS 1135 Waivers, and Joint Commission standards.

PPE Videos

Consistent with CDC recommendations as of March 24, 2020

Joint Commission FAQs 

CDC Guidance

Note: CDC Updates infection prevention and control guidance during the COVID pandemic regularly. Please refer to this guidance in addition to the resources listed here.

CMS Guidance

FDA Resources

Preparing for COVID-19 Vaccination

Other Resources

Infographics

Blog

Resources Specific to Re-opening

Some communities in the United States have not been hit with the COVID-19 pandemic yet. These materials are targeted for those who are still preparing:
Staff Health and Wellbeing resources:
Watch webinar replays and read communications from The Joint Commission:
Webinar Replays

Hospital Q&A Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, life safety and 1135 waivers.

Home Care Q&A Webinars

Leaders from The Joint Commission answer questions on topics including infection prevention and control, 1135 waivers and telehealth. 

Laboratory Q&A Webinar

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety, CMS 1135 Waivers, and Joint Commission standards.

Behavioral Health Care Q&A Webinar

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety, CMS 1135 waivers and Joint Commission standards.

Nursing Care Centers Q&A Webinar

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety, CMS 1135 Waivers, and Joint Commission standards.

Ambulatory Health Care Q&A Webinar

Leaders from The Joint Commission answer questions on topics including infection prevention and control, environment of care/life safety and Joint Commission standards.

Disease-Specific Care Q&A Webinar

Leaders from The Joint Commission answer questions on topics including infection prevention and control, 1135 waivers and Joint Commission standards.

Communications
  • October 26, 2020 – Status of Onsite Survey Activity
  • August 14, 2020 – Removal of Position Statement
  • May 27, 2020 – Regular Surveys and Reviews to Resume in June — With Some Changes to Protect Safety
  • May 12, 2020 – Statement on Removing Barriers to Mental Health Care for Clinicians and Health Care Staff.
  • April 23, 2020 – Universal Masking Statement.
  • April 6, 2020 – FAQ in Response to The Joint Commission Statement on Use of Face Masks Brought From Home.
  • April 1, 2020 – All Joint Commission surveys and reviews will remain on hold until the end of May.
  • March 31, 2020 – Joint Commission Statement on Use of Face Masks Brought From Home.
  • March 27, 2020 – Public Statement on the Shortages of Critical Medical Equipment.
  • March 16, 2020 – The Joint Commission is suspending all regular surveying.
  • March 9, 2020 – The Joint Commission continues to actively monitor COVID-19 activity.
  • February 25, 2020 – The Joint Commission believes it is time for hospitals to prepare for a possible surge of Coronavirus patients.
  • February 14, 2020 – Information and guidance on what your organization needs to know about COVID-19.
Joint Commission Advocacy Actions to Aid Health Care Organizations in Response to COVID-19:

For more information, visit our Federal Relations and Public Policy page.

Federal Relations and Public PolicyLearn more about Federal Relations and Public Policy

CDC Resources

FDA Resources

OSHA Resources

New OSHA Program: Policies and Procedures for Implementing a National Emphasis Program (NEP) – NEP ensures that employees with increased potential exposure to SARS-CoV-2 are protected from contracting the virus and are able to reporting issues without retaliation.

Additional resources:

Real Voices. Real Stories.

Just like many of you, Joint Commission enterprise staff who are also working on the front lines are facing real challenges. We’d like to share some of their personal experiences.

View storiesRead stories from Joint Commission staff working on the front lines of COVID-19

 

Disclaimer: The Joint Commission’s placement of content on this website is not an endorsement of the source nor of any particular product or service, nor should it be construed as a statement that the source, or its products or services, are superior to those of other companies. Website users acknowledge The Joint Commission may not be the primary source of the content. By accessing and using website resources, website users agree to make no claim of any kind against The Joint Commission for any and all damages that result from use or implementation of any website content. Some items included on these pages (such as Joint Commission monographs) were developed several years ago.  While much of the content remains relevant, users should be aware that the information has not been updated.